60 acast.com ePulmonology Review https://podcast.dkbmed.com/category/epulmonology en DKBmed 2019 ePulmonology Review ePulmonology Review podcast channel

Hosted on Acast. See acast.com/privacy for more information.

]]>

Hosted on Acast. See acast.com/privacy for more information.

]]> false ePulmonology Review info+5fa6e74a24d4fb37ae007c6d@mg-eu.acast.com 5fa6e74a24d4fb37ae007c6d epulmonologyreview https://podcast.dkbmed.com/feed/epulmonology/ episodic https://assets.pippa.io/shows/5fa6e74a24d4fb37ae007c6d/1606931297957-5f396aa3836c0c97b71c5b6db20c63a7.jpeg https://podcast.dkbmed.com/category/epulmonology ePulmonology Review https://feeds.acast.com/public/shows/5fa6e74a24d4fb37ae007c6d Clinical Management Considerations in Mild Asthma Clinical Management Considerations in Mild Asthma Thu, 21 Mar 2024 13:00:56 GMT 23:47 65e8879b734a930016ce3fad false https://elit.dkbmed.com/issues/197 65e8879b734a930016ce3fad 5fa6e74a24d4fb37ae007c6d clinical-management-considerations-in-mild-asthma full 3 4 Mild asthma. For patients showing wheezing and shortness of breath on moderate exertion, it’s one of the most common diagnoses, even when breath sounds are clear and pulmonary function testing is normal. 

What makes mild asthma “mild”? The key guidelines base the stage of a patient’s asthma on how difficult it is to treat. Does that mean the frequency of symptom occurrence? How often a rescue inhaler needs to be used? The frequency and severity of pulmonary exacerbations? 

How should mild asthma be treated? What are the risks and benefits of short-acting beta agonists versus long-acting beta agonists versus inhaled corticosteroids? Which combinations might be appropriate for which patients?

Join us in this issue of ePulmonology Review, as Dr. Fawzy from the Johns Hopkins University School of Medicine’s Division of Pulmonary and Critical Care discusses these and other issues important to providing the best care for patients with mild asthma.


Post test for CME/CE credit: https://elit.dkbmed.com/issues/197/test

Hosted on Acast. See acast.com/privacy for more information.

]]> Mild asthma. For patients showing wheezing and shortness of breath on moderate exertion, it’s one of the most common diagnoses, even when breath sounds are clear and pulmonary function testing is normal. 

What makes mild asthma “mild”? The key guidelines base the stage of a patient’s asthma on how difficult it is to treat. Does that mean the frequency of symptom occurrence? How often a rescue inhaler needs to be used? The frequency and severity of pulmonary exacerbations? 

How should mild asthma be treated? What are the risks and benefits of short-acting beta agonists versus long-acting beta agonists versus inhaled corticosteroids? Which combinations might be appropriate for which patients?

Join us in this issue of ePulmonology Review, as Dr. Fawzy from the Johns Hopkins University School of Medicine’s Division of Pulmonary and Critical Care discusses these and other issues important to providing the best care for patients with mild asthma.


Post test for CME/CE credit: https://elit.dkbmed.com/issues/197/test

Hosted on Acast. See acast.com/privacy for more information.

]]> PH in the Clinic: The Revised WHO Classifications PH in the Clinic: The Revised WHO Classifications Thu, 08 Feb 2024 12:00:46 GMT 25:30 65b7e8ed2ed1750016de594c false https://elit.dkbmed.com/issues/195 65b7e8ed2ed1750016de594c 5fa6e74a24d4fb37ae007c6d ph-in-the-clinic-the-revised-who-classifications full 3 2 Pulmonary hypertension. The 2022 ESC/ERS revised guidelines have redefined it. New evidence from ongoing and completed clinical trials have led to updates in diagnostic thresholds and treatment algorithms. New agents — some approved, others advancing through the pipeline — promise improved efficacy and safety for a variety of patients. What does it all mean to practitioners in the clinic?


Post test for CME/CE credit: https://elit.dkbmed.com/issues/195/test

Hosted on Acast. See acast.com/privacy for more information.

]]> Pulmonary hypertension. The 2022 ESC/ERS revised guidelines have redefined it. New evidence from ongoing and completed clinical trials have led to updates in diagnostic thresholds and treatment algorithms. New agents — some approved, others advancing through the pipeline — promise improved efficacy and safety for a variety of patients. What does it all mean to practitioners in the clinic?


Post test for CME/CE credit: https://elit.dkbmed.com/issues/195/test

Hosted on Acast. See acast.com/privacy for more information.

]]> COVID-19: Then and Now COVID-19: Then and Now Mon, 07 Nov 2022 19:32:02 GMT 25:36 62cd945aa218a600120fb960 false https://shows.acast.com/epulmonologyreview/episodes/covid-19-then-and-now 62cd945aa218a600120fb960 5fa6e74a24d4fb37ae007c6d covid-19-then-and-now full 2 5

Hosted on Acast. See acast.com/privacy for more information.

]]>

Hosted on Acast. See acast.com/privacy for more information.

]]> Steroids, Dyspnea, and COVID: Clinical Challenges in COPD Management Steroids, Dyspnea, and COVID: Clinical Challenges in COPD Management Wed, 30 Mar 2022 13:29:51 GMT 19:23 622774fb6f48ef00123407b0 false https://shows.acast.com/epulmonologyreview/episodes/steroids-dyspnea-and-covid-clinical-challenges-in-copd-manag 622774fb6f48ef00123407b0 5fa6e74a24d4fb37ae007c6d steroids-dyspnea-and-covid-clinical-challenges-in-copd-manag full 2 4 In early 2022, the state of the art for managing patients with COPD continues to present challenges. When, how, and in whom are inhaled steroids the most effective way to reduce exacerbations? Are the GOLD guidelines still relevant? What do patients with COPD need to know about the dangers and long-term effects of COVID-19 infection?  

These are some of the questions we discuss with our guest, Dr. Nirupama Putcha from the Division of Pulmonology and Critical Care at the Johns Hopkins University School of Medicine, in this issue of ePulmonology Review. 


Take our post-test to claim CME credits.

Hosted on Acast. See acast.com/privacy for more information.

]]> In early 2022, the state of the art for managing patients with COPD continues to present challenges. When, how, and in whom are inhaled steroids the most effective way to reduce exacerbations? Are the GOLD guidelines still relevant? What do patients with COPD need to know about the dangers and long-term effects of COVID-19 infection?  

These are some of the questions we discuss with our guest, Dr. Nirupama Putcha from the Division of Pulmonology and Critical Care at the Johns Hopkins University School of Medicine, in this issue of ePulmonology Review. 


Take our post-test to claim CME credits.

Hosted on Acast. See acast.com/privacy for more information.

]]> Asthma Management: The Current State of the Art in Early 2022 Asthma Management: The Current State of the Art in Early 2022 Tue, 08 Mar 2022 15:23:49 GMT 19:57 622774a86d92ed00132c84e0 false https://shows.acast.com/epulmonologyreview/episodes/asthma-management-the-current-state-of-the-art-in-early-2022 622774a86d92ed00132c84e0 5fa6e74a24d4fb37ae007c6d asthma-management-the-current-state-of-the-art-in-early-2022 full 2 2 Managing patients with asthma continues to grow more complex. Two key guidelines have recently been updated. Where do their recommendations concur? Where do they differ, and why? Where do the newer biologic agents fit into evolving treatment paradigms? Which patients are likely to benefit, and in which are specific biologics inappropriate? 

These are some of the questions we discuss with Dr. Ashraf Fawzy, from the Division of Pulmonology and Critical Care at Johns Hopkins University, in this ePulmonology Review podcast. 


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Managing patients with asthma continues to grow more complex. Two key guidelines have recently been updated. Where do their recommendations concur? Where do they differ, and why? Where do the newer biologic agents fit into evolving treatment paradigms? Which patients are likely to benefit, and in which are specific biologics inappropriate? 

These are some of the questions we discuss with Dr. Ashraf Fawzy, from the Division of Pulmonology and Critical Care at Johns Hopkins University, in this ePulmonology Review podcast. 


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> <![CDATA[Pulmonary Hypertension: Clinical Workup & Diagnosis]]> Tue, 11 Sep 2018 16:43:40 GMT 29:15 https://podcast.dkbmed.com/?p=165 false https://shows.acast.com/epulmonologyreview/episodes/5fa6e74f887b4d49490a5847 5fa6e74f887b4d49490a5847 5fa6e74a24d4fb37ae007c6d The complexity of pulmonary hypertension and the importance of a rigorous diagnostic workup. full 1 6 In this podcast Dr. Paul Hasson from Johns Hopkins explains the complexity of pulmonary hypertension and the importance of a rigorous diagnostic workup and describes the basic diagnostic algorithm to accurately classify the type of pulmonary hypertension encountered in a specific patient.

Take our post-test to claim CME credits:Physician post-testNurse post-test

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> In this podcast Dr. Paul Hasson from Johns Hopkins explains the complexity of pulmonary hypertension and the importance of a rigorous diagnostic workup and describes the basic diagnostic algorithm to accurately classify the type of pulmonary hypertension encountered in a specific patient.

Take our post-test to claim CME credits:Physician post-testNurse post-test

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> COPD: Inhaled Strategies in the Clinic COPD: Inhaled Strategies in the Clinic Thu, 07 Jun 2018 22:21:35 GMT 28:00 https://podcast.dkbmed.com/?p=140 false https://shows.acast.com/epulmonologyreview/episodes/5fa6e74f887b4d49490a5848 5fa6e74f887b4d49490a5848 5fa6e74a24d4fb37ae007c6d The evidence describing the preferred treatment for symptomatic patients with COPD who have a low risk of exacerbations. The role of supplemental oxygen therapy in patients with COPD. full 1 4 In this podcast, Dr. Nadia Hansel discusses the evidence describing the preferred treatment for symptomatic patients with COPD who have a low risk of exacerbations, describes the evidence for the preferred treatment strategy for patients with GOLD grade D COPD, and explains the role of supplemental oxygen therapy in patients with COPD.

Take our post-test to claim CME credits:Physician post-testNurse post-test

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> In this podcast, Dr. Nadia Hansel discusses the evidence describing the preferred treatment for symptomatic patients with COPD who have a low risk of exacerbations, describes the evidence for the preferred treatment strategy for patients with GOLD grade D COPD, and explains the role of supplemental oxygen therapy in patients with COPD.

Take our post-test to claim CME credits:Physician post-testNurse post-test

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> COPD Clinical Insight: Increasing Medication Adherence COPD Clinical Insight: Increasing Medication Adherence Tue, 10 Apr 2018 20:28:37 GMT 26:09 https://podcast.dkbmed.com/?p=104 false https://shows.acast.com/epulmonologyreview/episodes/5fa6e74f887b4d49490a5849 5fa6e74f887b4d49490a5849 5fa6e74a24d4fb37ae007c6d Patient risk factors that are associated with poor medication use in COPD. The high prevalence of medication nonadherence and its negative impact on clinical outcomes in patients with COPD. full 1 2 In this podcast, Dr. Michelle Eakin from Johns Hopkins University School of Medicine discusses the high prevalence of medication nonadherence and its negative impact on clinical outcomes in patients with COPD, identifying patient risk factors that are associated with poor medication use in COPD, and and describes efficacious interventions to support medication adherence.

Take our post-test to claim CME credits:Physician post-testNurse post-test

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> In this podcast, Dr. Michelle Eakin from Johns Hopkins University School of Medicine discusses the high prevalence of medication nonadherence and its negative impact on clinical outcomes in patients with COPD, identifying patient risk factors that are associated with poor medication use in COPD, and and describes efficacious interventions to support medication adherence.

Take our post-test to claim CME credits:Physician post-testNurse post-test

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]>